Review
Version 1
Preserved in Portico This version is not peer-reviewed
Molecular Modulators of Adipogenesis as Treatment Options for Obesity
Version 1
: Received: 24 June 2021 / Approved: 25 June 2021 / Online: 25 June 2021 (12:09:51 CEST)
How to cite: Goshu, B. T. Molecular Modulators of Adipogenesis as Treatment Options for Obesity. Preprints 2021, 2021060620. https://doi.org/10.20944/preprints202106.0620.v1 Goshu, B. T. Molecular Modulators of Adipogenesis as Treatment Options for Obesity. Preprints 2021, 2021060620. https://doi.org/10.20944/preprints202106.0620.v1
Abstract
Abstract: As a risk factor, obesity is a threat to human well-being and related metabolic disorders such as diabetes mellitus and dyslipidemia. adipogenesis is defined as the proliferation and maturation of adipocyte predecessor cells to adipocyte. As the adipogenesis process decides adipocyte production, it may be considered a therapeutic target for obesity and obesity-related disorders. White adipose tissue abnormal expansion increases the size and number of adipocytes. For that reason, this review aims to spot the molecular mechanisms implicated in adipogenesis that lead to application in the therapeutic targets. Keywords: adipogenesis, signaling pathways, anti-obesity treatment, obesity
Keywords
adipogenesis; signaling pathways; anti-obesity treatment; obesity
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment